What is the risk of myocarditis after mRNA-based COVID-19 vaccination in the US as calculated from the underreported VEARS system?
These rates appear to be a little low and I am unsure how they were able to divide myocarditis post vaccination in 12 to 15 year old boys by vaccination type in 12 to 15 year old boys.
Someone found a way to identify these people from people of all ages. Maybe genomics?
The rates of myocarditis cases were highest after the second vaccination dose in adolescent males aged:
— 16 to 17 years (105.9 per million doses of the BNT162b2 vaccine)
— 12 to 15 years old (70.7 per million doses of the BNT162b2 vaccine)— 18 to 24 years (52.4 and 56.3 per million doses of the BNT162b2 vaccine and the mRNA-1273 vaccine, respectively)
Conclusion
Based on passive surveillance reporting in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased across multiple age and sex strata and was highest after the second vaccination dose in adolescent males and young men.
Recommended for you
